Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy of Eszopiclone in improving short and intermediate-term compliance with continuous positive airway pressure (CPAP) in patients newly diagnosed with obstructive sleep apnea (OSA).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Walter Reed Army Medical Center
• Collaborator: Sunovion
• Treatments: Eszopiclone

Criteria

Inclusion Criteria:

• Adult patients

• Newly diagnosed with OSA who are prescribed CPAP therapy

Exclusion Criteria:

• Patients < 18 years old

• Patients over 65 years

• Pregnant women

• Patients with chronic liver disease

• Patients who abuse alcohol

• Patients taking narcotics or using sedative-hypnotic agents such as Ambien, Klonopin or Benadryl